" rel="stylesheet">
Skip Main Navigation
Page Content
This event has ended

Sept 2012 Forum: The State Of Crowdfunding

Tech Coast Venture Network

Thursday, September 27, 2012 from 6:00 PM to 9:00 PM (PDT)

Sept 2012 Forum: The State Of Crowdfunding

Ticket Information

Ticket Type Sales End Price Fee Quantity
Non-TCVN Member Ended $25.00 $0.00
Non-TCVN Member (At Event) Ended $35.00 $0.00
Student   more info Ended $10.00 $0.00

Who's Going

Loading your connections...

Share Sept 2012 Forum: The State Of Crowdfunding

Event Details

The State of Crowdfunding


A TCVN Forum

One of the most innovative and exciting sections of the new Jumpstart Our Business Startups Act (the “JOBS Act”) creates a new “crowdfunding” exemption from state and federal securities law registration.  Through this new exemption, issuers and investors may communicate by way of the Internet in connection with the issuance of new securities.  This aspect of the JOBS Act has the potential to create new funding opportunities for companies from an extremely broad pool of investors, including even unsophisticated investors.  But, . . .  at what cost?

Come listen to Crowdfunding expert, Howard Leonhardt, discuss the issues with a special, one-on-one, fireside chat with start-up lawyer and TCVN Chair Emeritus, Bart Greenberg.

Speaker: Howard Leonhardt - Serial Entrepreneur

Howard Leonhardt is an inventor and serial entrepreneur.  He has 20 U.S. patents for products for treating cardiovascular and heart disease.  These include;  cardiovascular balloon catheters, stent grafts for aneurysm repair, percutaneous heart valves, heart pacemakers with stem cell recruiting capabilities, electrical stimulation devices for promoting blood flow, electrical stimulation device for converting stem cells to heart muscle, stem cell compositions for heart repair, stem cell delivery systems, biological pacemakers and artificial lung catheter.  His TALENT stent graft developed in the early 1990′s holds a leading world market share for repairing aortic aneurysms without surgery.  His inventions have treated over 140,000 patients in 60 countries. In early 1999 Leonhardt founded Bioheart, Inc. www.bioheartinc.com a leader in applying adult muscle stem cells to treat heart failure.  Bioheart has raised over $105 million in paid in capital and additionally $40 million in loans and grants.  Bioheart MyoCell is in Phase II/III clinical trials at 33 leading centers in the USA (The MARVEL Study).  MARVEL Phase II/IIIa part I results were published in the American Heart Journal October of 2011 and demonstrated Bioheart MyoCell patients improved 95.7 meters in exercise capacity over placebo patients receiving optimal CHF drugs, whom declined minus 4 meters.  Leonhardt holds a Diploma in International Trade from Anoka Technical College.  He attended the University of Minnesota and Anoka Ramsey Community College.  He holds an honorary Doctorate in Biomedical Engineering from the University of Northern California and is an honorary alumnus of the University of Florida and Florida International University where he has served on various boards.  He was South Florida Entrepreneur of the Year 2003 and State of Florida Entrepreneur of the Year 2004.  Leonhardt has founded 20 companies to date, most them majority funded by his venture firm Leonhardt Ventures and their associated angel networks www.leonhardtventures.com.  These include;  The California Stock Xchange www.calstockexchange.com, Kindheart Lionheart Adventures www.lionheartadventures.com, MyoStim Pacers www.myostimpacers.com, Leonhardt Vineyards www.leonhardtvineyards.com, Leonhardt’s Launchpads www.leonhardtslaunchpads.com, Kindheart Lionheart Media Co. www.kindheartlionheart.com, Stem Cell Bra www.stemcellbra.com and Wine Country Baseball www.winecountrybaseball.com.  Leonhardt helps lead Startup California www.startupcalifornia.org a region of the Startup America Partnership as a spokesperson on the JOBS ACT and Crowdfunding.   He founded the public policy institute The Entrepreneurship Party www.entrepreneurshipparty.com in 2006 and is an independent candidate for the Governorship of California 2014 http://howardleonhardt.nationbuilder.com/ and www.howardleonhardt.org


Moderator: Bart Greenberg - Partner, Haynes and Boone, LLP

 Bart Greenberg is a partner in Haynes and Boone's Orange County office, practicing general corporate law with an emphasis on mergers and acquisitions, debt and equity financings and the cost-effective representation of entrepreneurs, start-ups and emerging technology companies.  Bart is also a strong contributor to the community by his tireless support and active involvement in many local technology organizations, including, among others, Tech Coast Venture Network, where he currently serves as its Chairman; TechBiz Connection, where he currently serves on its Board; and the Digital Media Center in Santa Ana, California, where he currently serves on its Advisory Board.  Bart is also an active participant on Quora.

Register Today!

$25 for non-TCVN Members pre-registration
$35 at the door/day of event

$10 for students with valid I.D.

TCVN members please email techcoastventurenetwork@gmail.com to receive your FREE ticket!


Thank You to Our Sponsors!

Knobbe  Hall&Co

  HaynesBoone  JacksonDeMarco  CEO Advisor  TriNet

Have questions about Sept 2012 Forum: The State Of Crowdfunding? Contact Tech Coast Venture Network

When & Where

2040 Main Street - 2nd Floor
Irvine, 92614

Thursday, September 27, 2012 from 6:00 PM to 9:00 PM (PDT)

  Add to my calendar


Tech Coast Venture Network

TCVN is one of Southern California’s premier technology business networks. Through a wide variety of forums, pitch sessions, workshops, and other networking events, we bring together entrepreneurs and resources from every facet of the technology and startup landscape.

  Contact the Organizer
Sept 2012 Forum: The State Of Crowdfunding
Irvine, United States Events Conference

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.